Consequences of CYP3A4 and MDR-1 polymorphisms on pharmakokinetic parameters of cyclosporin a and mycophenolic acid in pediatric renal transplant recipients.

被引：0
|
作者：
Feneberg, Reinhard
Weber, Lutz T.
van Asen, Nicolas
Armstrong, Victor W.
Hoecker, Britta
Oellerich, Michael
Toenshoff, Burkhard
机构：
[1] Univ Heidelberg, Dept Pediat Nephrol, Heidelberg, Germany
[2] Univ Munich, Dept Pediat Nephrol, Munich, Germany
[3] Univ Gottingen, Dept Clin Chem, D-3400 Gottingen, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2007年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
849
引用
收藏
页码：366 / 367
页数：2
相关论文
共 50 条
  • [31] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    TRANSPLANTATION, 2014, 98 : 618 - 618
  • [32] CYP3A4, CYP3A5 and MDR-1 variant alleles in the Dutch Caucasian population.
    van Schaik, R
    van der Werf, M
    van der Heiden, IP
    Dorrestein, S
    Brosens, R
    Thiadens, A
    van Iperen, N
    van Fessem, M
    van Vliet, M
    de Wildt, SN
    van den Anker, J
    Lindemans, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P42 - P42
  • [33] A new CYP3A4 polymorphism is associated with an increased risk of renal toxicity in cyclosporin-treated kidney transplant recipients
    Elens, L.
    Bouamar, R.
    Hesselink, D.
    Haufroid, V
    van Gelder, T.
    van Schaik, R.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 480 - 480
  • [34] CYP3A5 and MDR1 polymorphisms in pediatric kidney transplant recipients receiving calcineurin inhibitors
    Tirelli, Amedea Silvia
    Ghio, Luciana
    Ferraresso, Mariano
    Belingheri, Mirco
    Berardinelli, Luisa
    Turolo, Stefano
    Torresani, Erminio
    Edefonti, Alberto
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 544 - 544
  • [35] CYP3A4 genetic polymorphisms predict cyclosporine-related clinical events in Chinese renal transplant recipients
    WANG Yu-yuan
    ZHANG Ming
    LU Fu-ming
    JIAO Zheng
    QIU Xiao-yan
    中华医学杂志（英文版）, 2012, (23) : 4233 - 4238
  • [36] CYP3A4 genetic polymorphisms predict cyclosporine-related clinical events in Chinese renal transplant recipients
    Wang Yu-yuan
    Zhang Ming
    Lu Fu-ming
    Jiao Zheng
    Qiu Xiao-yan
    CHINESE MEDICAL JOURNAL, 2012, 125 (23) : 4233 - 4238
  • [37] Impact of the MDR-1 C3435T polymorphism on tacrolimus doses and trough concentrations in renal transplant recipients.
    Anglicheau, D
    Verstruyf, C
    Schlageter, MH
    Thervet, E
    Becquemont, L
    Beaune, P
    Legendre, C
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 360A - 361A
  • [38] In Vivo Hepatic CYP3A4 Activity Is Significantly Higher in Tacrolimus Treated vs Cyclosporine Treated Renal Transplant Recipients.
    de Jonge, Hylke
    Naesens, Maarten
    Verbeke, Kristin
    Vanrenterghem, Yves
    Kuypers, Dirk R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 573 - 573
  • [39] Influence of Cyp3a4, Cyp3a5 and Mdr1-C3435t Genetic Polymorphisms in Tacrolimus Pharmacokinetics in Adult Renal Transplant Patients
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Seoane-Pillado, M. T.
    Pedreira-Vazquez, I
    Martin-Herranz, I
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 657 - 658
  • [40] Effect of MDR1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    Vanhove, Thomas
    Annaert, Pieter
    Kuypers, Dirk R. J.
    TRANSPLANTATION, 2016, 100 (07) : S167 - S168
12345